Grant Davis
Psychiatric/Mental Health · Richardson, TXNPI 1396136693
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $318,219 of the $360,264 with a category attached, or 88.3%. 22 manufacturers reported payments, led by AbbVie at 45.8% of the total. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 949 payments — averaging $379.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$165K
- Johnson & Johnson$146K
- Axsome Therapeutics, Inc.$25K
- Otsuka America Pharmaceutical, Inc.$21K
- Lundbeck LLC$628
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$560
- plus $2K from 16 others
What the payments were for
- Consulting fees$16,2895%
- Speaking & faculty fees$318,21988%
- Travel & lodging$12,2483%
- Food & beverage$13,5084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 404 | $165,059 |
| Johnson & Johnson | 195 | $146,362 |
| Axsome Therapeutics, Inc. | 50 | $24,845 |
| Otsuka America Pharmaceutical, Inc. | 106 | $20,647 |
| Lundbeck LLC | 32 | $628 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $560 |
| Vanda Pharmaceuticals Inc. | 27 | $537 |
| Corium, LLC | 21 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $275 |
| Sunovion Pharmaceuticals Inc. | 16 | $259 |
| Tris Pharma Inc | 18 | $206 |
| Eisai Inc. | 10 | $129 |
| Supernus Pharmaceuticals, Inc. | 5 | $127 |
| Almatica Pharma LLC | 3 | $62 |
| Neos Therapeutics, LP | 3 | $54 |
| Ironshore Pharmaceuticals Inc. | 3 | $46 |
| Noven Therapeutics, LLC | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Alkermes, Inc. | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Validus Pharmaceuticals LLC | 1 | $22 |
| Bausch Health US, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$360,264 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $90,416 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 47 | $483 |
| Bupropion XlBupropion Hcl | 32 | $410 |
| Trazodone Hcl | 26 | $358 |
| Duloxetine Hcl | 23 | $323 |
| Gabapentin | 15 | $202 |
| Escitalopram Oxalate | 39 | $185 |
| Hydroxyzine Pamoate | 19 | $148 |
| Alprazolam | 31 | $74 |
| Clonazepam | 32 | $72 |
| Lamotrigine | 11 | $65 |
| Quetiapine Fumarate | 11 | $3 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Richardson
- Karah BrashierRichardson$567K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
- Tamekia ScaggsFort Worth$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.